Literature DB >> 26640962

Aptamer-Enabled Manipulation of the Hsp70 Chaperone System Suggests a Novel Strategy for Targeted Ubiquitination.

Deepak Thirunavukarasu1, Hua Shi1.   

Abstract

The Hsp70 chaperone system plays an important role in protein quality control by assisting in the folding and clearance of misfolded proteins. However, the mechanism by which it chooses between folding and degradation pathways is not fully understood. In this study, we used an RNA aptamer for Hsp70 to perturb the function of Hsp70 in cell-free systems. We found that the aptamer inhibited both Hsp70-mediated folding and Hsp70-CHIP-mediated ubiquitination/degradation of a misfolded protein substrate. Based on these results, we explored a novel strategy for targeted protein ubiquitination, using an engineered bifunctional aptamer to tether a protein substrate to Hsp70. We demonstrated that increased Hsp70-CHIP-mediated ubiquitination of the tethered protein substrate can be specifically induced by this bifunctional aptamer. This strategy may be useful in selective degradation of disease-causing proteins for therapeutic purposes. In addition, these studies provide insight into the mechanism of Hsp70-mediated protein triage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26640962      PMCID: PMC4753623          DOI: 10.1089/nat.2015.0563

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  50 in total

1.  The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins.

Authors:  P Connell; C A Ballinger; J Jiang; Y Wu; L J Thompson; J Höhfeld; C Patterson
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

2.  Multistep mechanism of substrate binding determines chaperone activity of Hsp70.

Authors:  M P Mayer; H Schröder; S Rüdiger; K Paal; T Laufen; B Bukau
Journal:  Nat Struct Biol       Date:  2000-07

3.  Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.

Authors:  Andiliy Lai; Mehmet Kahraman; Steven Govek; Johnny Nagasawa; Celine Bonnefous; Jackie Julien; Karensa Douglas; John Sensintaffar; Nhin Lu; Kyoung-Jin Lee; Anna Aparicio; Josh Kaufman; Jing Qian; Gang Shao; Rene Prudente; Michael J Moon; James D Joseph; Beatrice Darimont; Daniel Brigham; Kate Grillot; Richard Heyman; Peter J Rix; Jeffrey H Hager; Nicholas D Smith
Journal:  J Med Chem       Date:  2015-05-22       Impact factor: 7.446

Review 4.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

5.  Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer.

Authors:  Donald P McDonnell; Suzanne E Wardell; John D Norris
Journal:  J Med Chem       Date:  2015-06-03       Impact factor: 7.446

6.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

7.  Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2.

Authors:  J Nylandsted; M Rohde; K Brand; L Bastholm; F Elling; M Jäättelä
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

8.  An RNA aptamer specific to Hsp70-ATP conformation inhibits its ATPase activity independent of Hsp40.

Authors:  Deepak Thirunavukarasu; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2015-02-05       Impact factor: 5.486

9.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

10.  Role of Hsc70 binding cycle in CFTR folding and endoplasmic reticulum-associated degradation.

Authors:  Yoshihiro Matsumura; Larry L David; William R Skach
Journal:  Mol Biol Cell       Date:  2011-06-22       Impact factor: 4.138

View more
  2 in total

1.  RNA aptamers targeted for human αA-crystallin do not bind αB-crystallin, and spare the α-crystallin domain.

Authors:  Prabhat K Mallik; Hua Shi; Jayanti Pande
Journal:  Biochem Biophys Res Commun       Date:  2017-07-15       Impact factor: 3.575

Review 2.  Degradation of proteins by PROTACs and other strategies.

Authors:  Yang Wang; Xueyang Jiang; Feng Feng; Wenyuan Liu; Haopeng Sun
Journal:  Acta Pharm Sin B       Date:  2019-08-13       Impact factor: 11.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.